ECPC Director, Antonella Cardone, shared new information on the impact of COVID-19 on the cancer patient community. The full video can be found down below.

The European Association for Bioindustries (EuropaBio) interviewed Antonella Cardone, the Director of ECPC on the impact of COVID-19 on the cancer patient community. She shared information about how ECPC approached the challenges due to COVID-19 and how the coalition advises cancer patients during these times.

“The most striking effects of covid-19 on the EU cancer patient community is due to the fact that cancer patients belong to the highest risk population, as they suffer from the most severe effects of COVID-19. According to the data from Italy, they are at a higher risk of losing their life due to COVID-19. In fact, in Italy, data shows that more than 20% of all deaths due to COVID-19 are among cancer patients.”

Watch the video interview and learn more about the ECPC perspective on novel gene therapies and other innovative cancer treatments that are on the horizon, and how these are perceived in the patient community.